Investment Readiness for Healthtech & Innovation-Led Businesses
What Investors Need to Trust When Growth, R&D and Runway All Matter
Innovation creates a different kind of financial story.
Product development may come before scale. Teams can grow ahead of revenue. R&D, regulatory and commercial milestones influence timing.
This guide connects investment, milestones, commercial progress, cash requirements and future value.
What this Guide will help you understand
Milestones and runway
Connect cash to what the business must achieve next.
R&D and growth spend
Explain what expenditure is intended to unlock.
Scenario planning
Make uncertainty visible rather than hiding it.
Group visibility
Build finance routines that match cross-border complexity.
Board reporting
Use information to support decisions, not simply document them.
Due diligence
Strengthen evidence before the request arrives.
Innovation changes the shape of the finance story
The business may need investment precisely because it is not yet operating like a mature company.
Investors understand that.
What they still expect is clarity.
A useful finance story should connect:
investment → milestones → commercial progress → cash requirements → future value
Six finance disciplines that improve investor confidence
Runway by Milestone
Do not only ask “How many months of cash do we have?”
Ask “What needs to be achieved before that cash runs out?”
Runway should be considered alongside:
- technical milestones;
- commercial milestones;
- hiring;
- trials or validation;
- market entry;
- revenue development;
- and likely future funding.
Cash without context can create false comfort.
R&D and Growth Spend Need Different Conversations
Management should understand which expenditure is:
- essential to reaching the next milestone;
- accelerating something that already works;
- discretionary;
- or increasing fixed cost before commercial evidence exists.
Investors will want to understand why money is being spent and what it unlocks.
Forecasts Should Acknowledge Uncertainty
An innovation-led forecast is not strengthened by pretending uncertainty does not exist.
It is strengthened by showing management understands it.
Use scenarios around:
- launch timing;
- customer adoption;
- recruitment;
- pricing;
- international expansion;
- regulatory/commercial milestones;
- manufacturing or fulfilment;
- and subsequent funding.
One precise-looking forecast can be less useful than several well-considered scenarios.
Group Visibility Matters Earlier Than Expected
Cross-border growth may create requirements for:
- entity-level reporting;
- consolidated group reporting;
- cross-border cash visibility;
- currency planning;
- consistent reporting routines;
- and clearer responsibility between jurisdictions.
The finance function needs to grow with the structure of the business.
Management Reporting Should Help Decisions
A growth board does not need twenty pages of numbers nobody uses.
It needs enough information to understand:
- what changed;
- why it changed;
- the effect on cash/runway;
- whether milestones remain achievable;
- and where a decision is required.
Good board reporting creates a conversation.
It does not simply document one.
Due Diligence Starts Before the Data Room Opens
Ask early:
- Can we reconcile the model to actual performance?
- Can we explain material assumptions?
- Can we provide consistent group information?
- Is decision-making documented?
- Can senior management explain the financial story?
- Are known process/control weaknesses already being addressed?
Readiness is created before the request arrives.
Neurofenix
Julia supported Neurofenix as the business expanded into the US and prepared for investor scrutiny, helping build UK, US and group finance foundations alongside forecasting, cashflow planning, reporting and due diligence.
That work formed part of the financial infrastructure around a successful £5.5m Series A.
The important point is not simply the number. It is the discipline behind it: Clarity before scrutiny.
Five-minute leadership test
- What are our next three financially significant milestones?
- How much cash is required to reach each one?
- Which assumptions create the greatest downside risk?
- What changes first if funding takes longer?
- Which parts of finance will stop scaling before the rest of the business?
- What will an investor struggle to understand if they review our numbers tomorrow?
Those questions can expose more than another beautifully formatted model.
Get the Healthtech Investment Readiness Leadership Checklist
Receive the leadership questions and finance-readiness framework to review internally before investor scrutiny increases.
Healthtech investment readiness FAQs
Is investor readiness different for healthtech businesses?
The fundamentals remain financial credibility, but innovation-led businesses often need to connect runway with technical, regulatory and commercial milestones more explicitly.
Should R&D spend be treated differently from general growth spend?
Management should at minimum understand what each major area of spend is intended to unlock and how it relates to milestones and runway.
How much scenario planning is enough?
There is no universal number. Focus on scenarios around the variables most capable of changing runway, milestones or funding requirements.
When should due-diligence preparation begin?
Before the data room opens. Early preparation exposes gaps while there is still time to improve them.
Innovation may create the opportunity. Financial clarity helps leadership explain how that opportunity becomes commercially credible.
Continue with the next useful step
Investment Readiness Assessment
Identify where finance foundations are strongest and where evidence needs attention.
Neurofenix Case Study
See how joined-up finance supported US expansion and a successful £5.5m Series A.
Investment Readiness Support
Explore senior finance leadership for businesses preparing for investors, boards and due diligence.